CAS 139314-01-5
:Quilostigmine
- Quilostigmine [USAN]
- (3aS,8aR)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl 3,4-dihydro-2(1H)-isoquinolinecarboxylate
- 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl ester, (3aS-cis)
- Hp 290
- Nxx 066
- Unii-2L1Yno4Sqj
- (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl 3,4-dihydroisoquinoline-2(1H)-carboxylate
Quilostigmine
CAS :Quilostigmine is a cholinergic.Formule :C23H27N3O2Couleur et forme :SolidMasse moléculaire :377.48Quilostigmine
CAS :Produit contrôléApplications Quilostigmine is an acetylcholinesterase inhibitor used for Alzheimer's disease treatment.
References Snape, M., et al.: Neuropharmacology, 38, 181 (1999); Dahlin, M., Bjork, E.: Int. J. Pharm., 212, 267 (2001); Chaudhaery, S., et al.: J. Med. Chem., 53, 6490 (2010);Formule :C23H27N3O2Couleur et forme :NeatMasse moléculaire :377.479Quilostigmine
CAS :Quilostigmine is a molecule that binds to the nicotinic acetylcholine receptor and inhibits ion channels. It is used in research as a pharmacological tool for studying the function of ion channels, as well as for its potential use in the treatment of Alzheimer's disease. Quilostigmine has been shown to be an inhibitor of cholinesterase, which breaks down acetylcholine, and may have therapeutic applications in treating myasthenia gravis. Quilostigmine is currently being researched for its ability to inhibit protein interactions with ligands and receptors. This drug is also an antibody-binding reagent that can be used in cell biology and immunology experiments to identify cells or antibodies.
Formule :C23H27N3O2Degré de pureté :Min. 95%Masse moléculaire :377.50 g/mol


